On this page
novavax
Explore " novavax" with insightful episodes like "The Pharma and Biotech Daily Podcast: The Latest in COVID-19 Vaccines and Treatments", "Episode 116: You Can Indict the Covid Criminals!", "Novavax booster, COVID vaccines in pregnancy and boosters for kids with Sandra Fryhofer, MD", "FDA authorizes Novavax vaccine for kids ages 12-17 with Andrea Garcia, JD, MPH" and "Novavax vaccine questions answered with Sandra Fryhofer, MD" from podcasts like ""Pharma and BioTech Daily", "The Free America Podcast", "AMA Update", "AMA Update" and "AMA Update"" and more!
Episodes (22)
Episode 116: You Can Indict the Covid Criminals!
Richard Fleming, Ph.D., MD, JD
https://www.flemingmethod.com/
https://crimesagainsthumanitytour.com/
Telegram - https://t.me/usa10letters
Youtube - https://www.youtube.com/channel/UCGkb1u2JSM7iuz0wMOpiAWA
Rumble - https://rumble.com/account/content?type=all
Book - "Is COVID-19 a Bioweapon? A Scientific and Forensic Investigation" https://www.skyhorsepublishing.com/978151 0770201/is-covid-19-a-bioweapon/
Help Support Free America!
Subscribe - www.FreeAmericaPodcast.com
Follow - https://www.instagram.com/freeamericapodcast/
Support - Get your Covid's Most Wanted cards here! With 30% OFF and FREE SHIPPING!
https://www.etsy.com/shop/CovidsMostWanted?coupon=CHRISTMAS
News Items
https://amidwesterndoctor.substack.com/p/the-most-important-dataset-of-the
Novavax booster, COVID vaccines in pregnancy and boosters for kids with Sandra Fryhofer, MD
FDA authorizes Novavax vaccine for kids ages 12-17 with Andrea Garcia, JD, MPH
Novavax vaccine questions answered with Sandra Fryhofer, MD
Monkeypox, Omicron BA.5, and Novavax with Andrea Garcia, JD, MPH
Expanded Approval for Gout Drug + Novavax COVID-19 Vaccine Gets FDA Authorization
In this episode, Ayesha discussed the FDA authorization of Novavax’s COVID-19 vaccine, making it the fourth authorized/approved COVID vaccine in the US. It is also the first protein-based COVID-19 vaccine to be authorized in the country. While the vaccine offers an alternate option to people who may still be hesitant about mRNA vaccines, hear why some experts think it won’t have much of an impact on those who are choosing to remain unvaccinated.
Ayesha also talked about the expanded label approval of Horizon Therapeutics’ gout medication Krystexxa to include its co-administration with arthritis and chemotherapy drug methotrexate. The new approved combination is indicated for the treatment of uncontrolled gout, a rare condition in which patients fail to respond to conventional treatments due to problems including drug resistance. Hear more about gout and the rare condition of uncontrolled gout in this episode.
Read the full articles here:
Novavax Vaccine Becomes First FDA-Authorized Protein Vaccine for COVID-19
Krystexxa Chronic Gout Medication Gets Expanded FDA Approval
For more life science and medical device content, visit the Xtalks Vitals homepage.
Follow Us on Social Media
Twitter: @Xtalks
Instagram: @Xtalks
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured
FDA authorizes emergency use of Novavax COVID-19 vaccine
Ahora trámites migratorios pueden hacerse por internet
- Video filtrado provoca ira y dolor a familiares de víctimas del pistolero en la escuela Robb.
- En Washington manifestantes exigen al congreso mayor control de armas.
- Fuertes lluviosa en Virginia ocasionan inundaciones.
- Investigan rastros de químico herbicida en estadounidenses.
- Anuncio público explica cómo responder a un ataque nuclear.
- Starbucks anuncia el cierre de 16 tiendas en EE.UU.
- Investigan si incendio en California fue un acto intencional.
- Enfrentamientos entre integrantes de caravana migratoria.
- Repatrian restos de mexicanos fallecidos en San Antonio, Texas.
- FDA autoriza el uso de emergencia de la vacuna de Novavax.
The new Covid vaccine, the capitol riots hearing, Janet Yellen's remarks on inflation, and the 100% successful drug trial
A potential new Covid vaccine option, the upcoming hearings on the capitol riots, Janet Yellen’s remarks on current inflation, and also the drug trial where 100% of participants came out cancer free. Let’s be informed so we can get on with our day.
Support the showFDA to review COVID vaccine for kids under 5 with Andrea Garcia, JD, MPH
On May 9th, AMA's immediate past president, Susan Bailey, MD, will host the live webinar: "Fourth dose boosters and pediatric vaccine update with Dr. Peter Marks." Register for the AMA's webinar: https://www.ama-assn.org/delivering-care/public-health/covid-19-webinar-series-fourth-dose-boosters-and-pediatric-vaccines
Andrea Garcia, JD, MPH, covers new CDC study findings, full FDA approval for Moderna vaccine & Novavax authorization request
What You Should Know Before Getting A Booster
The NSW, VIC and SA governments recently decided to reduce the time between our second COVID-19 jab and third booster shots to just three months, but does the shorter timeframe mean your vaccine could be less effective?
And what about choosing between Pfizer or Moderna; how do you know which one you should get? Does it matter? Does it depend on which vaccine you had for round one and two?
The Quicky speaks to our favourite GP to find out the answers to these and many more questions about Australia's booster program, including whether there is any truth to reports that a third injection can miraculously heal a variety of skin conditions overnight.
CREDITS
Host: Claire Murphy
With thanks to:
Dr Brad McKay - Science communicator, TV host, author and podcaster who works as a GP in Sydney. He is also the author of Fake Medicine: Exposing the wellness crazes, cons and quacks costing us our health
Producer: Claire Murphy
Executive Producer: Siobhán Moran-McFarlane
Audio Producer: Ian Camilleri
Subscribe to The Quicky at... https://mamamia.com.au/the-quicky/
CONTACT US
Got a topic you'd like us to cover? Send us an email at thequicky@mamamia.com.au
GET IN TOUCH:
Feedback? We’re listening! Call the pod phone on 02 8999 9386 or email us at podcast@mamamia.com.au
Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander cultures.
Just by reading or listening to our content, you’re helping to fund girls in schools in some of the most disadvantaged countries in the world - through our partnership with Room to Read. We’re currently funding 300 girls in school every day and our aim is to get to 1,000. Find out more about Mamamia at mamamia.com.au
Become a Mamamia subscriber: https://www.mamamia.com.au/subscribe
See omnystudio.com/listener for privacy information.
Is Novavax really better than the mRNA vaccines?
Can you Rate and Give us a Review in Apple Podcasts?
- Please go to Pandemic on Apple Podcasts to leave a review. Thank you!
Please consider financially supporting us for the monthly upkeep and helping hand off some of the editing responsibilities. You can give a one-time donation or become a Patreon member for as little as $5 a month. See the links below. Thank you!
- Give a one-time gift through Venmo at @mattboettger
- Give a one-time gift through PayPal here.
- Give monthly (as little as $5 a month) on our Patreon Page.
Things Discussed on Episode:
- Man believed to have longest COVID-19 infection had virus for 300 days
- COVID live updates: Delta variant can spread within '5 to 10 seconds' of exposure
- Dangerous Delta COVID-19 Variant Infecting Vaccinated Adults In Israel
- We’re Not Ready for Another Pandemic
- The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better
- CDC says roughly 4,100 people have been hospitalized or died with Covid breakthrough infections after vaccination
Dr. Mira Irons shares insights on continuing vaccination efforts and Novavax details
Morning Bell 15 June
On the Aussie COVID-19 vaccine front - Novavax’s COVID-19 vaccine candidates showed strong efficacy against the virus. This sparks good news for Australia’s vaccine strategy – as the federal Government has made the Novavax shot one of the key parts of its rollout and has 51 million doses placed on order.
Given, the news of the Novavax vaccine, as well as the reasonably positive start to Wall Street’s week, the Aussie share market looks set to lift 0.80% or 56 points higher to 7,368 points if you go by the futures.
US eco data out this week includes retail sales data for May, which is out today at 10:30pm AEST and on Thursday, the Fed will announce their interest rate decision.
What to watch today:
- In economic news, today the RBA releases its meeting minutes, and house price index data is out. On Thursday, the unemployment rate for May will be announced and RBA Governor Lowe will deliver a speech titled ‘From recovery to expansion’.
- The oil price held steady after hitting a 2-year high, while the gold price slipped as investors fear the US Fed may outline a path for scaling back its expansive monetary policy at its two-day meeting this week.
- The most traded stocks by Bell Direct clients last Friday were ANZ Bank (ASX:ANZ), Westpac (ASX:WBC) and Queensland Pacific Metals (ASX:QPM).
Trading ideas:
- Bell Potter have reiterated their BUY recommendation on Domino’s Pizza (ASX:DMP), with an increased price target of $132 (previously $122). Domino’s closed about 1% up last Friday to $115.30, which implies 14.4% share price growth.
- Bell Potter has also increased its price target on Portman’s and Peter Alexander owner Premier Investments (ASX:PMV) to $26.10 (previously $25). PMV expects its Earnings before Interest and Tax to range between $340 - $360 million, which is 5-11% ahead of Bell Potter’s estimate of $344 million. This positive expectation is off the back of a strong sales performance, strong online sales growth, and strong cost control. However, with its share price currently at $27.44, that implies a negative 4.9% share price growth, therefore Bell Potter have a HOLD rating on the stock.
- IOUpay (ASX:IOU), Lynas Rare Earths (ASX:LYC) and Cyprium Metals (ASX:CYM) are also giving off bullish charting signals according to Trading Central.